201 related articles for article (PubMed ID: 7507474)
1. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease.
Okada T; Takiura F; Tokushige K; Nozawa S; Kiyosawa T; Nakauchi H; Hirose S; Shirai T
Eur J Immunol; 1991 Nov; 21(11):2743-8. PubMed ID: 1718758
[TBL] [Abstract][Full Text] [Related]
3. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia.
Shirai T; Okada T; Hirose S
Ann N Y Acad Sci; 1992 May; 651():509-26. PubMed ID: 1376072
[TBL] [Abstract][Full Text] [Related]
4. Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model.
Hirose S; Hamano Y; Shirai T
Leukemia; 1997 Apr; 11 Suppl 3():267-70. PubMed ID: 9209361
[TBL] [Abstract][Full Text] [Related]
5. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
6. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
Schena M; Larsson LG; Gottardi D; Gaidano G; Carlsson M; Nilsson K; Caligaris-Cappio F
Blood; 1992 Jun; 79(11):2981-9. PubMed ID: 1375120
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
Shirai T
Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
[TBL] [Abstract][Full Text] [Related]
8. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
Cioca DP; Kitano K
Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
[TBL] [Abstract][Full Text] [Related]
10. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
Rassenti LZ; Kipps TJ
J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
13. The NZB mouse as a model for chronic lymphocytic leukemia.
Phillips JA; Mehta K; Fernandez C; Raveché ES
Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
[TBL] [Abstract][Full Text] [Related]
14. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
15. Influence of host environment on growth of clonal CD5+B (Lyl+B) cells.
Raveche ES; Lin TZ; Conroy J; Tjio JH; Steinberg AD; Rudolfsky UA; Phillips JA
Autoimmunity; 1991; 10(3):217-25. PubMed ID: 1721848
[TBL] [Abstract][Full Text] [Related]
16. Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.
Nganga VK; Palmer VL; Naushad H; Kassmeier MD; Anderson DK; Perry GA; Schabla NM; Swanson PC
Blood; 2013 May; 121(19):3855-66, S1-16. PubMed ID: 23502221
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory capability of murine CLL-like CD5+ B cells.
Phillips J; Raveché E
Ann N Y Acad Sci; 1992 May; 651():488-90. PubMed ID: 1376068
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice.
Hamano Y; Hirose S; Ida A; Abe M; Zhang D; Kodera S; Jiang Y; Shirai J; Miura Y; Nishimura H; Shirai T
Blood; 1998 Nov; 92(10):3772-9. PubMed ID: 9808571
[TBL] [Abstract][Full Text] [Related]
19. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.
Efanov A; Zanesi N; Nazaryan N; Santanam U; Palamarchuk A; Croce CM; Pekarsky Y
Leukemia; 2010 May; 24(5):970-5. PubMed ID: 20357824
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
